Systems announced a collaboration with a global pharmaceutical manufacturer on a Phase III clinical trial for an expanded ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

With more than 325,000 pumps installed worldwide, the Plum A+™ general purpose infusion system remains the proven choice for caregivers and clinicians alike. The scalable platform can be ...

The poster titled “ Preclinical and Translational Pharmacokinetics of GD2-SADA, a Self-Assembling and Disassembling (SADA) Bispecific Fusion Protein for Pretargeted Radioimmunotherapy (PRIT)” ...